Trials / Unknown
UnknownNCT05333835
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
A 26-week, Randomized, Open-label, 3-arm Parallel, Treat-to-target Study Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin With or Without One Other Oral Anti-diabetic Drug
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 455 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to compare the efficacy and safety of HR17031 versus INS068 and SHR20004 in subjects with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR17031 injection | HR17031 injection |
| DRUG | INS068 injection | INS068 injection |
| DRUG | SHR20004 injection | SHR20004 injection |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2024-03-30
- Completion
- 2024-03-30
- First posted
- 2022-04-19
- Last updated
- 2023-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05333835. Inclusion in this directory is not an endorsement.